Resonance Health Analysis Services Pty Ltd

Click Here To EMAIL INQUIRY
Contact: Andrew Bathgate
Web: http://www.resonancehealth.com
E-Mail:
Address: Level 1, 216 Stirling Highway, Claremont 6010, Australia
Phone: +61-(8)-9286-5300 | Fax: +61-(8)-9286-1179 | Map/Directions >>

Profile: Resonance Health Analysis Services Pty Ltd develops MRI image analysis technologies for the diagnosis and monitoring of human diseases. Our Ferriscan® is a non-invasive imaging alternative to liver biopsy for quantifying liver iron.

FDA Registration Number: 3005450718
US Agent: Robyn Scopis / Regulatory Specialists, Inc.
Phone: +1-(949)-262-0411 Fax: +1-(949)-552-2821 E-Mail:

15 Products/Services (Click for related suppliers)

• Clinical Diagnostic Laboratory Services

• Clinical Trial Project Management Services

• Consultants, Regulatory Assistance

• Ferrozine Iron Binding Capacity Test (FDA Code: JMO / 862.1415)

An iron-binding capacity test system is a device intended to measure iron-binding capacity in serum. Iron-binding capacity measurements are used in the diagnosis and treatment of anemia.

• Image Analysis System

• Liver Biopsy kit

• Medical Imaging Consulting Service

• MRI (Magnetic Resonance Imaging)

• MRI (Magnetic Resonance Imaging) Accessories

• MRI Compatable Patient Monitors

• MRI Devices

• MRI Imaging

• MRI Systems

• Nuclear Magnetic Resonance Imaging System (FDA Code: LNH / 892.1000)

A magnetic resonance diagnostic device is intended for general diagnostic use to present images which reflect the spatial distribution and/or magnetic resonance spectra which reflect frequency and distribution of nuclei exhibiting nuclear magnetic resonance. Other physical parameters derived from the images and/or spectra may also be produced. The device includes hydrogen-1 (proton) imaging, sodium-23 imaging, hydrogen-1 spectroscopy, phosphorus-31 spectroscopy, and chemical shift imaging (preserving simultaneous frequency and spatial information).

• Protocol Development Service